Q2 2016 Holdings
Filed 2016-08-15 | 22 holdings | $1.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $773.0K | 135,800 | 58.6% |
| Medivation, Inc. | COM | 58501N101 | $265.2K | 4,397,838 | 20.1% |
| Champions Oncology Inc(CSBR) | COMM NEW | 15870P307 | $239.0K | 111,111 | 18.1% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $7.7K | 2,563,925 | 0.6% |
| Synthetic Biologics Inc. | COM | 87164U102 | $6.7K | 3,734,149 | 0.5% |
| Alcobra Ltd | SHS | M2239P109 | $5.0K | 1,115,315 | 0.4% |
| Ampio Pharmaceuticals Inc. | COM | 03209T109 | $4.2K | 3,238,322 | 0.3% |
| Vascular Biogenics LTD | COM | M96883109 | $4.0K | 860,605 | 0.3% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $3.2K | 1,359,767 | 0.2% |
| Cempra Inc | COM | 15130J109 | $3.0K | 180,800 | 0.2% |
| Advaxis Inc. | COM NEW | 7624208 | $2.2K | 275,000 | 0.2% |
| Volition RX LTD(VNRX) | COM | 928661107 | $1.5K | 461,538 | 0.1% |
| Keryx Biopharmaceuticals Inc. | COM | 492515101 | $1.3K | 200,000 | 0.1% |
| Newlink Genetics Corp | COM | 651511107 | $1.2K | 102,437 | 0.1% |
| OHR Pharmaceutical Inc | COM NEW | 67778H200 | $562 | 205,000 | 0.0% |
| Advaxis Inc. | W EXP 07/15/201 | 7624117 | $502 | 112,500 | 0.0% |
| Bio Blast Pharma Ltd | SHS | M20156101 | $402 | 250,970 | 0.0% |
| Evoke Pharma Inc | COM | 30049G104 | $381 | 55,660 | 0.0% |
| Caladrius Biosciences Inc | COM | 128058104 | $328 | 555,781 | 0.0% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $224 | 49,947 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $29 | 11,933 | 0.0% |
| Zosano Pharma Corp | COM | 98979H103 | $15 | 11,195 | 0.0% |